Cyfuse Biomedical K.K. (TYO:4892)
Japan
· Delayed Price · Currency is JPY 977.00
-5.00 (-0.51%)
Apr 28, 2025, 3:30 PM JST
Cyfuse Biomedical K.K. Market Cap
Cyfuse Biomedical K.K. has a market cap or net worth of 7.71 billion as of April 28, 2025. Its market cap has increased by 39.77% in one year.
Market Cap
7.71B
Enterprise Value
5.51B
Revenue
54.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
977.00
Market Cap Chart
Since December 1, 2022, Cyfuse Biomedical K.K.'s market cap has decreased from 13.00B to 7.71B, a decrease of -40.68%. That is a compound annual growth rate of -19.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 7.75B | 117.26% |
| Dec 30, 2024 | 3.57B | -40.10% |
| Dec 29, 2023 | 5.96B | -37.68% |
| Dec 30, 2022 | 9.56B | -26.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 13.62T |
| Daiichi Sankyo Company | 6,564.20B |
| Takeda Pharmaceutical Company | 6,512.32B |
| HOYA Corporation | 5,670.71B |
| Terumo | 4,075.20B |
| Otsuka Holdings | 3,525.91B |
| Astellas Pharma | 2,473.03B |
| Olympus | 2,051.39B |